Sarepta Therapeutics Cash from Other Financing Activities (Quarterly) Insights

Sarepta Therapeutics, Inc. (SRPT)

18.88 +0.29 (+1.56%) USD | NASDAQ | Feb 20, 16:00

18.79 -0.09 (-0.48%) Pre-Market: 08:36

View Cash from Other Financing Activities (Quarterly) for SRPT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Cash from Other Financing Activities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Cash from Other Financing Activities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Cash from Other Financing Activities (Quarterly) Benchmarks

Start Trial

Arrowhead Pharmaceuticals, Inc.	Upgrade
Merck & Co., Inc.	Upgrade
Pfizer Inc.	Upgrade
REGENXBIO, Inc.	Upgrade
Keros Therapeutics, Inc.	--